Regulations.gov document
Draft Guidance for Industry on Referencing Discontinued Labeling for Listed Drugs in…
Notice · FDA-2000-D-0272 · posted Oct 15, 2015
Key facts
| Document ID | FDA-2000-D-0272-0001 |
|---|---|
| Title | Draft Guidance for Industry on Referencing Discontinued Labeling for Listed Drugs in Abbreviated New Drug Applications |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2000-D-0272 |
| Posted | Oct 15, 2015 |
| Comment period opens | Oct 15, 2015 |
| Comments due | Jan 25, 2001 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: